Increased pulsatility index is associated with adverse outcomes in left ventricular assist device recipients
Jazyk angličtina Země Anglie, Velká Británie Médium print-electronic
Typ dokumentu časopisecké články, práce podpořená grantem
PubMed
34346192
PubMed Central
PMC8497202
DOI
10.1002/ehf2.13537
Knihovny.cz E-zdroje
- Klíčová slova
- Clinical events, Mechanical circulatory support, Pulsatility index,
- MeSH
- ateroskleróza * MeSH
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- podpůrné srdeční systémy * MeSH
- senioři MeSH
- srdeční selhání * MeSH
- výsledek terapie MeSH
- Check Tag
- dospělí MeSH
- lidé středního věku MeSH
- lidé MeSH
- senioři MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
AIMS: Recipients of left ventricular assist devices (LVAD) are exposed to increased risk of adverse clinical events. One of the potential contributing factors is non-pulsatile flow generated by LVAD. We evaluated the association of flow patterns in carotid arteries and of increased arterial stiffness with death and cerebrovascular events in LVAD recipients. METHODS AND RESULTS: We analysed data from 83 patients [mean age 54 ± 15 years; 12 women; HeartMate II (HMII), n = 34; HeartMate 3 (HM3), n = 49]. Pulsatile and resistive indexes, atherosclerotic changes in carotid arteries (measured by duplex ultrasound), and arterial stiffness [measured by Endo-PAT 2000 as the augmentation index standardized for heart rate (AI@75)] were evaluated 3 and 6 months after LVAD implantation. Sixteen patients died during follow-up (27.3 months; interquartile range 15.7-44.3). After adjusting for the main variables examined, the pulsatility index measured at 3 months was positively associated with increased hazard ratios (HR) for death and cerebrovascular events [HR 9.8, 95% confidence interval (CI) 1.62-59.42], with HR increasing after adding AI@75 to the model (HR 18.8, 95% CI 2.44-145.50). In HM3 recipients, HR was significantly lower than in HMII recipients (HR 0.31, 95% CI 0.11-0.91), but the significance disappeared after adding AI@75 to the model (HR 0.33, 95% CI 0.09-1.18). CONCLUSIONS: The risk of death and cerebrovascular events in LVAD recipients is associated with increased pulsatility index in carotid arteries and potentiated by increased arterial stiffness. The same risk is attenuated by HM3 LVAD implantation, but this effect is weakened by increased arterial stiffness.
2nd Faculty of Medicine Charles University Prague Czech Republic
Department of Cardiology Institute for Clinical and Experimental Medicine Prague Czech Republic
Department of Pathophysiology 2nd Faculty of Medicine Charles University Prague Czech Republic
Department of Physiology 3rd Faculty of Medicine Charles University Prague Czech Republic
Institute of Physiology 1st Faculty of Medicine Charles University Prague Czech Republic
Zobrazit více v PubMed
Goldstein DJ, Meyns B, Xie R, Cowger J, Pettit S, Nakatani T, Netuka I, Shaw S, Yanase M, Kirklin JK. Third Annual Report From the ISHLT Mechanically Assisted Circulatory Support Registry: A comparison of centrifugal and axial continuous‐flow left ventricular assist devices. J Heart Lung Transplant. 2019; 38: 352–363. PubMed
Kirklin JK, Pagani FD, Kormos RL, Stevenson LW, Blume ED, Myers SL, Miller MA, Baldwin JT, Young JB, Naftel DC. Eighth annual INTERMACS report: Special focus on framing the impact of adverse events. J Heart Lung Transplant. 2017; 36: 1080–1086. PubMed
Acharya D, Loyaga‐Rendon R, Morgan CJ, Sands KA, Pamboukian SV, Rajapreyar I, Holman WL, Kirklin JK, Tallaj JA. INTERMACS Analysis of Stroke During Support With Continuous‐Flow LeftVentricular Assist Devices: Risk Factors and Outcomes. JACC Heart Fail. 2017; 5: 703–711. PubMed PMC
Zimpfer D, Gustafsson F, Potapov E, Pya Y, Schmitto J, Berchtold‐Herz M, Morshuis M, Shaw SM, Saeed D, Lavee J, Heatley G, Gazzola C, Garbade J, the ELEVATE Investigators . Two‐year outcome after implantation of a full magnetically levitated left ventricular assist device: results from the ELEVATE Registry. Eur Heart J 2020; 41: 3801–3809. PubMed
Ivak P, Pitha J, Wohlfahrt P, Kralova Lesna I, Stavek P, Dorazilova Z, Stepankova J, Maly J, Pokorny M, Netuka I. Endothelial dysfunction expressed as endothelial microparticles in patients with end‐stage heart failure. Physiol Res 2014; 63: S369–S373. PubMed
Ivak P, Pitha J, Wohlfahrt P, Kralova Lesna I, Stavek P, Melenovsky V, Dorazilova Z, Hegarova M, Stepankova J, Maly J, Sekerkova A. Biphasic response in number of stem cells and endothelial progenitor cells after left ventricular assist device implantation: A 6month follow‐up. Int J Cardiol. 2016; 218: 98–103. PubMed
Ivak P, Netuka I, Kralova‐Lesna I, Wohlfahrt P, Pitha J. Changes in circulating stem cells and endothelial progenitor cells over a 12‐month period after implantation of a continuous‐flow left ventricular assist device. Arch Med Sci 2020; 16: 1440–1443. PubMed PMC
Cornwell WK 3rd, Ambardekar AV, Tran T, Pal JD, Cava L, Lawley J, Tarumi T, Cornwell CL, Aaronson K. Stroke Incidence and Impact of Continuous‐Flow Left Ventricular Assist Devices on Cerebrovascular Physiology. Stroke 2019; 50: 542–548. PubMed PMC
Kabbani LS, Munie S, Lin J, Velez M, Isseh I, Brooks S, Leix S, Shepard AD. Flow Patterns in the Carotid Arteries of Patients with Left Ventricular Assist Devices. Ann Vasc Surg 2017; 39: 182–188. PubMed
Coutsoumpos A, Patel S, Teruya TH, Chiriano J, Bianchi C, Abou‐Zamzam AM Jr. Carotid duplex ultrasound changes associated with left ventricular assist devices. Ann Vasc Surg 2014; 28: 1030.e7–1030.e11. PubMed
Wohlfahrt P, Krajcoviechova A, Jozifova M, Mayer O, Vanek J, Filipovsky J, Laurent S, Cifkova R. Large artery stiffness and carotid flow pulsatility in stroke survivors. J Hypertens 2014; 32: 1097–1103 discussion 1103. PubMed
Netuka I, Ivák P, Tucanová Z, Gregor S, Szárszoi O, Sood P, Crandall D, Rimsans J, Connors JM, Mehra MR. Evaluation of low‐intensity anti‐coagulation with a fully magnetically levitated centrifugal‐flow circulatory pump‐the MAGENTUM 1 study. J Heart Lung Transplant. 2018; 37: 579–586. PubMed
Belcaro G, Nicolaides AN, Laurora G, Cesarone MR, De Sanctis M, Incandela L, Barsotti A. Ultrasound morphology classification of the arterial wall and cardiovascular events in a 6‐year follow‐up study. Arterioscler Thromb Vasc Biol 1996; 16: 851–856. PubMed
Flammer AJ, Anderson T, Celermajer DS, Creager MA, Deanfield J, Ganz P, Hamburg NM, Lüscher TF, Shechter M, Taddei S, Vita JA, Lerman A. The assessment of endothelial function: from research into clinical practice. Circulation 2012; 126: 753–767. PubMed PMC
Yang WI, Park S, Youn JC, Son NH, Lee SH, Kang SM, Jang Y. Augmentation index association with reactive hyperemia as assessed by peripheral arterial tonometry in hypertension. Am J Hypertens 2011; 24: 1234–1238. PubMed
Templeton DL, John R, Painter P, Kelly AS, Dengel DR. Effects of the left ventricular assist device on the compliance and distensibility of the carotid artery. Heart Vessels 2013; 28: 377–384. PubMed
Segura AM, Gregoric I, Radovancevic R, Demirozu ZT, Buja LM, Frazier OH. Morphologic changes in the aortic wall media after support with a continuous‐flow left ventricular assist device. J Heart Lung Transplant. 2013; 32: 1096–1100. PubMed
Imamura T, Nguyen A, Kim G, Raikhelkar J, Sarswat N, Kalantari S, Smith B, Juricek C, Rodgers D, Ota T, Song T, Jeevanandam V, Sayer G, Uriel N. Optimal haemodynamics during left ventricular assist device support are associated with reduced haemocompatibility‐related adverse events. Eur J Heart Fail 2019; 21: 655–662. PubMed PMC
Ambardekar AV, Hunter KS, Babu AN, Tuder RM, Dodson RB, Lindenfeld J. Changes in Aortic Wall Structure, Composition, and Stiffness With Continuous‐Flow Left Ventricular Assist Devices: A Pilot Study. Circ Heart Fail 2015; 8: 944–952. PubMed
Witman MA, Garten RS, Gifford JR, Groot HJ, Trinity JD, Stehlik J, Nativi JN, Selzman CH, Drakos SG, Richardson RS. Further Peripheral Vascular Dysfunction in Heart Failure Patients With a Continuous‐Flow Left Ventricular Assist Device: The Role of Pulsatility. JACC Heart Fail. 2015; 3: 703–711. PubMed PMC
Bartoli CR, Spence PA, Siess T, Raess DH, Koenig SC, Dowling RD. Nonphysiologic blood flow triggers endothelial and arterial remodeling in vivo: implications for novel left ventricular assist devices with a peripheral anastomosis. J Thorac Cardiovasc Surg 2014; 148: 311–321. PubMed PMC
Mejía‐Rentería H, Matias‐Guiu JA, Lauri F, Yus M, Escaned J. Microcirculatory dysfunction in the heart and the brain. Minerva Cardioangiol 2019; 67: 318–329. PubMed
Mehra MR, Uriel N, Naka Y, Cleveland JC Jr, Yuzefpolskaya M, Salerno CT, Walsh MN, Milano CA, Patel CB, Hutchins SW, Ransom J, Ewald GA, Itoh A, Raval NY, Silvestry SC, Cogswell R, John R, Bhimaraj A, Bruckner BA, Lowes BD, Um JY, Jeevanandam V, Sayer G, Mangi AA, Molina EJ, Sheikh F, Aaronson K, Pagani FD, Cotts WG, Tatooles AJ, Babu A, Chomsky D, Katz JN, Tessmann PB, Dean D, Krishnamoorthy A, Chuang J, Topuria I, Sood P, Goldstein DJ, MOMENTUM 3 Investigators . A Fully Magnetically Levitated Left Ventricular Assist Device ‐ Final Report. N Engl J Med 2019; 380: 1618–1627. PubMed
Gustafsson F, Shaw S, Lavee J, Saeed D, Pya Y, Krabatsch T, Schmitto J, Morshuis M, Chuang J, Damme L, Zimpfer D, Garbade J. Six‐month outcomes after treatment of advanced heart failure with a full magnetically levitated continuous flow left ventricular assist device: report from the ELEVATE registry. Eur Heart J 2018; 39: 3454–3460. PubMed
Colombo PC, Mehra MR, Goldstein DJ, Estep JD, Salerno C, Jorde UP, Cowger JA, Cleveland JC Jr, Uriel N, Sayer G, Skipper ER, Downey FX, Ono M, Hooker R Jr, Anyanwu AC, Givertz MM, Mahr C, Topuria I, Somo SI, Crandall DL, Horstmanshof DA. Comprehensive Analysis of Stroke in the Long‐Term Cohort of the MOMENTUM 3 Study. Circulation 2019; 139: 155–168. PubMed
Mikkonen RH, Kreula JM, Virkkunen PJ. Peak systolic velocity, resistance index and pulsatility index. Variations in measuring a pre‐recorded videotape. Acta Radiol 1997; 38: 598–602. PubMed